Abstract | RATIONALE AIMS AND OBJECTIVES: With the achievement of longevity in hemodialysis patients, the risk of comorbid cancer has begun to draw attention. In the present study, we examined dialysis-related practice patterns and compared those patterns by cancer status. METHODS: Using data from the Japan Dialysis Outcomes and Practice Patterns Study phase 4, we evaluated 2153 hemodialysis patients. Baseline cancer status for patients was separated into 3 categories: no cancer, cancer with recent treatment, and cancer without recent treatment. We then assessed variations among hemodialysis patients in dialysis-related practice patterns, including anemia management, management of mineral and bone metabolism disorder, nutritional management, and dialysis treatment, by cancer status. RESULTS: CONCLUSION: Among long-term facility-based hemodialysis patients with cancer, we detected no statistically significant differences to suggest that cancer status affects hemodialysis practice regarding mineral and bone disorder management, nutritional management, and dialysis treatment. Facility-based hemodialysis patients with recent cancer treatment, however, receive a higher dose of erythropoietin-stimulating agent than those without cancer.
|
Authors | Hiroki Nishiwaki, Shingo Fukuma, Takeshi Hasegawa, Miho Kimachi, Tadao Akizawa, Shunichi Fukuhara |
Journal | Health science reports
(Health Sci Rep)
Vol. 1
Issue 7
Pg. e46
(Jul 2018)
ISSN: 2398-8835 [Electronic] United States |
PMID | 30623084
(Publication Type: Journal Article)
|